These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9114922)

  • 1. Observational study of accuracy in compounding i.v. admixtures at five hospitals.
    Flynn EA; Pearson RE; Barker KN
    Am J Health Syst Pharm; 1997 Apr; 54(8):904-12. PubMed ID: 9114922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for i.v. compounding errors when using an automated workflow management system.
    Deng Y; Lin AC; Hingl J; Huang G; Altaye M; Maynard H; Mayhaus D; Penm J
    Am J Health Syst Pharm; 2016 Jun; 73(12):887-93. PubMed ID: 27261239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.
    Gilbert RE; Kozak MC; Dobish RB; Bourrier VC; Koke PM; Kukreti V; Logan HA; Easty AC; Trbovich PL
    J Oncol Pract; 2018 May; 14(5):e295-e303. PubMed ID: 29676947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital.
    Moniz TT; Chu S; Tom C; Lutz P; Arnold A; Gura KM; Patterson A
    Am J Health Syst Pharm; 2014 Aug; 71(15):1311-7. PubMed ID: 25027539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units.
    Campino A; Santesteban E; Pascual P; Sordo B; Arranz C; Unceta M; Lopez-de-Heredia I
    Eur J Pediatr; 2016 Jun; 175(6):755-65. PubMed ID: 26670025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Offsite intravenous admixture center shared by health-system facilities.
    Fauber WS; Cosnotti SJ; Mady RL
    Am J Health Syst Pharm; 1995 Nov; 52(22):2550-5. PubMed ID: 8590238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Errors associated with the preparation of aseptic products in UK hospital pharmacies: lessons from the national aseptic error reporting scheme.
    Bateman R; Donyai P
    Qual Saf Health Care; 2010 Oct; 19(5):e29. PubMed ID: 20427304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large-scale, multicentre, multinational, retrospective study.
    Terkola R; Czejka M; Bérubé J
    J Clin Pharm Ther; 2017 Aug; 42(4):446-453. PubMed ID: 28429389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation.
    Allen LV
    Int J Pharm Compd; 2021; 25(3):222-229. PubMed ID: 34125713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the safety of intravenous admixtures: lessons learned from a Pentostam overdose.
    Just S; Schepers G; Piotrowski MM; Saint S; Kauffman CA
    Jt Comm J Qual Patient Saf; 2006 Jul; 32(7):366-72. PubMed ID: 16884123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations.
    Allen LV
    Int J Pharm Compd; 2021; 25(1):31-38. PubMed ID: 33503008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Errors detected in pediatric oral liquid medication doses prepared in an automated workflow management system.
    Bledsoe S; Van Buskirk A; Falconer RJ; Hollon A; Hoebing W; Jokic S
    Am J Health Syst Pharm; 2018 Feb; 75(3):127-131. PubMed ID: 29371193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation.
    Smith E; Fox A; Willmers G; Wright D; Stuart B
    Eur J Hosp Pharm; 2024 Apr; 31(3):220-226. PubMed ID: 36241376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review.
    Milibari L; Cotugno M; Belisle C; Rocchio M; Patterson RF; Chacon P; Fanikos J; Vo P
    Int J Pharm Compd; 2020; 24(4):346-351. PubMed ID: 32649308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study to evaluate the benefits of technology-assisted workflow on i.v. room efficiency, costs, and safety.
    Eckel SF; Higgins JP; Hess E; Cerbone T; Civiello JB; Conley C; Jafari N; Shah S; Speth SL; Thornton L
    Am J Health Syst Pharm; 2019 Jun; 76(12):895-901. PubMed ID: 31361850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for detecting medication errors in 36 hospitals and skilled-nursing facilities.
    Flynn EA; Barker KN; Pepper GA; Bates DW; Mikeal RL
    Am J Health Syst Pharm; 2002 Mar; 59(5):436-46. PubMed ID: 11887410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.